Adedayo Onitilo, M.D., Ph.D., medical director of Cancer Care & Research, was recently selected as a governing member of the SWOG Cancer Research Network Board of Governors.

SWOG Cancer Res‚Äčearch Network is a global cancer research community that designs and conducts publicly-funded clinical trials, including those funded by the National Cancer Institute.

“Our community cancer research program continues to perform arguably as best in the state, and one of the best in the country," said Dr. Onitilo. “I want to thank all of my colleagues and the research staff for continuing to excel nationally due to teamwork and hard work."

Dr. Onitilo was selected to represent the Cancer Care & Research Center at Marshfield Clinic Research Institute because of its three-year average annual accrual rate into cancer clinical trials and commitment to the high standards of data quality.

 “Participation in the board of governors ensures that the needs of our local cancer patients are being considered by SWOG as they advance their research program," said Daniel Wall, Cancer Care and Research Center administrator. “It also emphasizes the ongoing success of WiNCORP and our clinical trial programs."

About our cancer research program

The Wisconsin National Community Oncology Research Program (WiNCORP), a Wisconsin cancer clinical trial network, is a partnership between Gundersen Health System, Marshfield Clinic Health System and ThedaCare that provides innovative cancer clinical trials to patients in Wisconsin. This partnership builds on the collaborative relationship these three health systems have to improve access to cancer clinical trials.

The National Cancer Institute awarded WiNCORP with $15.6 million in 2019 to make the latest treatment options available to people with cancer. This will be the second time WiNCORP has received this award from the National Cancer Institute. During the first, five-year period, about 150 active cancer clinical trials were available at any given time. The National Cancer Institute has funded cancer clinical trials at the Health System since 1983.

WiNCORP as a whole received the Platinum Award in 2019 for excellence for exceptional patient enrollments from the National Cancer Institute, which is the highest level of recognition the program could have received.

“It is very rewarding to see our team at Cancer Care & Research Center being recognized for their expertise and hard work in cancer clinical trial accruals," said Amit Acharya, B.D.S., Ph.D. “We are proud to provide these important treatment options to the patients that need it."